Publications by authors named "Igor Nikitin"

Claim this Profile
Z
Zinc and Type 2 Diabetes: A Systematic Review with a Narrative Synthesis of Their Bidirectional Relationship and Clinical Perspectives for Personalized Nutritional Support.
Evgeniya Klein, Daria Velina, Sherzodkhon Mutallibzoda, Svetlana Tefikova, Olga Orlovtseva, Igor Nikitin

Diseases· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Machine Learning for the Discovery and Development of Multitarget Flavonoid-Based Functional Products in MASLD.
Maksim Kuznetsov, Evgeniya Klein, Daria Velina, Sherzodkhon Mutallibzoda, Olga Orlovtseva, Igor Nikitin

Molecules· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hair Mercury Levels in Pregnant Women: Fish Consumption as a Determinant of Exposure.
Olga Rumiantseva, Viktor Komov, Mikhail Kutuzov, Hicham Zaroual, Ksenia Mizina, Igor Nikitin

Toxics· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Social Well-Being on Population Diet Nutritional Value and Antiradical Status.
Victor Gorbachev, Igor Nikitin, Daria Velina, Natalia Zhuchenko, Alexander N Kosenkov

Foods· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the Mass of Food Components Necessary for the Utilization of Free Radical Particles in the Human Body.
Victor Gorbachev, Evgeny Nikulchev, Alexander N Kosenkov, Andrey Sokolov, Igor Zavalishin, Igor Nikitin

Int J Environ Res Public Health· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiradical Potential of Food Products as a Comprehensive Measure of Their Quality.
Victor Gorbachev, Maria Klokonos, Sherzodkhon Mutallibzoda, Svetlana Tefikova, Olga Orlovtseva, Igor Nikitin

Foods· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research into Morphofunctional Characteristics of Erythrocytes in COVID-19 Patients.
Victor Revin, Larisa Balykova, Sergey Pinyaev, Ilya Syusin, Olga Radaeva, Igor Nikitin

Biomedicines· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The origin of the hysteresis in cyclic voltammetric response of alkaline methanol electrooxidation.
Theresa Haisch, Fabian Kubannek, Lialia Nikitina, Igor Nikitin, Sabine Pott

Phys Chem Chem Phys· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
ST-elevation myocardial infarction, pulmonary embolism, and cerebral ischemic stroke in a patient with critically low levels of natural anticoagulants.
Elena Vladimirovna Reznik, Ekaterina Sergeevna Shcherbakova, Svetlana Vasilievna Borisovskaya, Yurij Valerevich Gavrilov, Tatyana Mikhailovna Pajeva, Igor Gennadievich Nikitin

J Cardiol Cases· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study.
Edward J Gane, Edwin DeJesus, Ewa Janczewska, Jacob George, Moises Diago, Igor Nikitin

BMC Infect Dis· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C.
Robert Flisiak, Mitchell Shiffman, Juan Arenas, Hugo Cheinquer, Igor Nikitin

PLoS One· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia.
Vasily Isakov, Igor Nikitin, Vladimir Chulanov, Pavel Ogurtsov, Ekaterina Lukyanova

World J Hepatol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial.
Stefan Zeuzem, Thomas Berg, Edward Gane, Peter Ferenci, Graham R Foster, Igor Nikitin

Gastroenterology· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study.
Michael W Fried, Maria Buti, Gregory J Dore, Robert Flisiak, Peter Ferenci, Igor Nikitin

Hepatology· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical management of drug-drug interactions in HCV therapy: challenges and solutions.
David Burger, David Back, Peter Buggisch, Maria Buti, Antonio Craxí, Igor Nikitin

J Hepatol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis